7 A meta-analysis of outcomes data from completed cardiovascular outcome trials suggests that, apart from saxagliptin, DPP-4 inhibitors have a neutral effect on the risk of cardiovascular death, myocardial infarction, stroke and hospitalisation for heart failure
If you live in North Dakota (the only state with no coverage as of April 2026) or your state covers it only for diabetes and you need it for weight loss, your options are paying cash ($1,100+ per month), applying for Lilly Cares if you're uninsured, or switching to compounded tirzepatide ($179 to $299 per month)
Although manufacturer savings cards and patient assistance programs may reduce costs for some commercially insured patients, these programs often exclude Medicare and Medicaid beneficiaries and frequently contain annual savings caps or eligibility limitations
By the end, youll be equipped to understand the risks, benefits, and best practices to protect your health while pursuing your weight loss goals
Understanding peptide testing limitations is essential for anyone evaluating product quality claims